Validation of the Novel International Association for the Study of Lung Cancer Grading System for Invasive Pulmonary Adenocarcinoma and Association With Common Driver Mutations
Authors:
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 16 (10) , 1684-1693
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81772466, 81930073, 81972171)
- Fudan University (IDF159045)
- Science and Technology Commission of Shanghai Municipality (2017SHZDZX01, VBH1323001/026)
- Shanghai Rising-Star Program (21QC1400600)
This publication has 31 references indexed in Scilit:
- Prognostic Significance of Predominant Histologic Pattern and Nuclear Grade in Resected Adenocarcinoma of the Lung: Potential Parameters for a Grading SystemJournal of Thoracic Oncology, 2013
- Comparative analyses of overall survival in patients with anaplastic lymphoma kinase‐positive and matched wild‐type advanced nonsmall cell lung cancerCancer, 2011
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: International Multidisciplinary Classification of Lung Adenocarcinoma: Executive SummaryProceedings of the American Thoracic Society, 2011
- Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I casesLaboratory Investigation, 2011
- A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I TumorsAmerican Journal of Surgical Pathology, 2010
- Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western PopulationClinical Cancer Research, 2009
- Mucinous Differentiation Correlates with Absence of EGFR Mutation and Presence of KRAS Mutation in Lung Adenocarcinomas with Bronchioloalveolar FeaturesThe Journal of Molecular Diagnostics, 2007
- Evolving Concepts in the Pathology and Computed Tomography Imaging of Lung Adenocarcinoma and Bronchioloalveolar CarcinomaJournal of Clinical Oncology, 2005
- Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non–Small-Cell Lung Cancer With Postoperative RecurrenceJournal of Clinical Oncology, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004